Is Campbell's Company (The) (CPB) a risky stock?
As of July 21, 2026, Clavix grades Campbell's Company (The) (CPB) C for risk, a composite score of 56 out of 100 on an A+ to F scale, which puts CPB in the "average" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 21, 2026. Clavix regrades every trading day.
The five risk dimensions behind CPB's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how CPB scores on each, as of July 21, 2026.
What's moving CPB's risk right now
Company-specific signals Clavix flags behind CPB's current grade, drawn from recent news and filings as of July 21, 2026.
Sigma Planning Corp increased its Campbell's position by 33.4% and Leonteq Securities AG lifted its stake by 37.2% during the first quarter. These are modest buys by smaller firms and don't signal a major shift in institutional news signal.
Campbell's shares have fallen about 20% while its dividend yield sits near 7%, suggesting investors are pricing in real risk. Cost cuts, AI investments, and the Rao's acquisition could lift margins and reignite growth if they deliver.
Campbell's rolled out a new soup lineup containing 20 grams of protein per can to appeal to health-minded shoppers. The product is aimed at defending its share in the core soup category against private-label and trendier rivals.
What a C grade means
On the Clavix A+ to F scale, CPB's composite of 56 falls in the C band (50–64), read as "average." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell CPB or any security. Grades are risk indicators, not predictions of return. Data may be delayed.